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Abstract: Here we describe the efficient synthesis of alkyl 4-arylsubstituted-6-chloro-5-
formyl-2-methyl-1,4-dihydropyridine-3-carboxylates and 4-arylsubstituted-4,7-dihydro-
furo[3,4-b]pyridine-2,5(1H,3H)-diones via microwave-accelerated reaction of alkyl  
4-arylsubstituted-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxylates with the 
appropriate reagents. This eco-friendly approach to these valuable dihydropyridine 
derivatives does not involve the harsh or highly contaminating conditions common in 
classical heating and offers a reduction or even elimination of solvent use and recovery, 
simplification of the work-up procedures, facility of scale up, and low energy consumption, 
in addition to moderate to higher yields. 
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1. Introduction 
Nitrogen heterocycles are frequently found in privileged (pharmacophore) structures [1,2], but their 
incorporation is often hindered (multistep sequences, lack of generality, preparation from acyclic 
precursors, etc.); thus, only a limited number of strategies have been successfully applied in the synthesis 
of heterocyclic scaffolds [3-5]. The development of new, rapid, and clean synthetic routes toward 
focused libraries of such compounds is of relevance to medicinal and synthetic chemists alike [6]. 
Undoubtedly, the most efficient strategies involve multicomponent reactions (MCRs), which are 
powerful tools for the rapid introduction of molecular diversity [7,8]. Consequently, interest in the 
design and development of MCRs for the generation of heterocycles is growing [9]. 
In recent years, increasing interest has been focused on the synthesis of 1,4-dihydropyridine 
derivatives (1,4-DHPs) owing to their significant biological activity [10-12]. In particular, 
dihydropyridine drugs, such as nifedipine, nicardipine, amlodipine, and others, are effective 
cardiovascular agents for the treatment of hypertension [13]. However, in spite of the potential utility 
of these drugs, their synthesis usually involves expensive reagents, organic solvents, long reaction 
times, and affords unsatisfactory yields. Thus, the development of an efficient and versatile method for 
the execution of of the Hantzsch reaction is an active ongoing field of research, and there is scope for 
further improvements in the form of milder reaction conditions, shorter reaction times, and improved 
yields [14-16]. 
The application of microwave irradiation (MW) as a non-conventional energy source for the 
activation of reactions, in general and under solvent-free conditions in particular, has now gained 
popularity compared to standard homogeneous and heterogeneous reactions because it provides 
enhanced reaction rates and (usually) improved product yields. In addition, in the context of green 
chemistry, MW irradiation has several eco-friendly advantages, which have been extended to modern 
drug discovery processes. Generally, the rapid heating induced by MW avoids the harsh classical 
conditions and decomposition of reagents, thus facilitating the formation of products under milder 
reaction conditions with a consequent increase in yield [17-19]. 
In the context of our general interest in MCRs and as part of our ongoing research programs into  
non-conventional synthesis as an eco-friendly approach to produce nitrogen heterocyclic compounds, 
here we report the MW-assisted synthesis (MWAS) of alkyl 4-arylsubstituted-6-chloro-5-formyl-2-
methyl-1,4-dihydropyridine-3-carboxylates II and 4-arylsubstituted-4,7-dihydrofuro[3,4-b]pyridine-
2,5(1H,3H)-diones III from alkyl 4-arylsubstituted-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridine-
carboxylates I. The 1,4-DHPs bearing the chlorine and formyl group proved to be useful intermediates 
for the synthesis of other pyridine-fused heterocycles (Figure 1). 
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Figure 1. Chemical structures of alkyl 4-arylsubstituted-2-methyl-6-oxo-1,4,5,6-
tetrahydro-3-pyridinecarboxylates I, alkyl 4-arylsubstituted-6-chloro-5-formyl-2-methyl-
1,4-dihydropyridine-3-carboxylates II and 4-arylsubstituted-4,7-dihydrofuro[3,4-b]pyridine- 
2,5(1H,3H)-diones III. 
 
2. Results and Discussion 
To obtain the alkyl 4-arylsubstituted-6-chloro-5-formyl-2-methyl-1,4-dihydropyridine-3-
carboxylates IIa–j and 4-arylsubstituted-4,7-dihydrofuro[3,4-b]pyridine-2,5(1H,3H)-dione DHP 
derivatives III, we previously synthesized alkyl 4-arylsubstituted-2-methyl-6-oxo-1,4,5,6-tetrahydro-
3-pyridinecarboxylates Ia–j. Briefly, compounds Ia–j were prepared under solvent-free conditions in a 
one-pot condensation reaction assisted by MW irradiation using the methods previously reported by 
our group [20,21]. When the irradiation was stopped, the solids were treated with appropriate solvents 
and filtered to give the pure products Ia–j in moderate to good yields (44%–89%). 
For the MWAS, the irradiation was provided by a CEM Discover LabMate Focused Single Mode 
MW Synthesis System, which allows for continuous stirring and irradiation with temperature control [22]. 
All the reactions were followed by TLC and the experiments were replicated in order to ensure 
reproducibility. 
2.1. Microwave Assisted Synthesis (MWAS) of Methyl 4-Arylsubstituted-6-chloro-5-formyl-2-methyl-
1,4-dihydropyridine-3-carboxylates IIa–j 
Some 6-chloro-5-formyl-1,4-dihydropyridine derivatives have been prepared by reaction of alkyl  
2-methyl 6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylates I with Vilsmeier-Haack reagent (POCl3, 
DMF) [12,23-25]; however, these reactions require long times (18 h) to obtain moderate or good 
yields. We recently reported on the ultrasound-assisted synthesis of these derivatives and found 
considerable improvements over conventional Vilsmeier-Haack chloroformylation [26]. In addition, 
MW irradiation has been used to accelerate the Vilsmeier-Haack formylations of pyrrole substrates [27]. 
The MWAS of compounds IIa–j was performed in a one-step procedure by reaction in an open 
vessel with previously prepared POCl3/DMF. The MW-accelerated Vilsmeier-Haack reaction is 
typically carried out in a MW reactor at 180 Watts and a controlled temperature of 50 °C for 5 min. 
Subsequent hydrolysis produces almost analytically pure compounds IIa–j, which requires minimal if 





















Molecules 2011, 16 9623 
 
 
Scheme 1. Synthesis of compounds IIa–j. 
 
Table 1 shows the results obtained for the MWAS of compounds IIa–j and the comparison with the 
classic method previously reported by our group (Method B) [24,25]. 
Table 1. Results of MWAS (Method A) of alkyl 4-arylsubstituted-6-chloro-5-formyl-2-
methyl-1,4-dihydropyridine-3-carboxylate (IIa–j) and comparison with the conventional 
method (Method B) [24,25]. 
Product R Ar Method T(°C)  t (min) Yield (%) 
IIa CH3 2-NO2-C6H4 A 50 5 69 
   B RT 1080 70 








































































In all cases, the yields for these compounds by MWAS (Method A) were slightly lower than those 
previously reported for conventional synthesis [24,25], although the reaction times were dramatically 
reduced from 18 h under conventional synthesis to 5 min for MWAS. With MW irradiation as an 
energy source, the partial decomposition of the Vilsmeier-Haack (VH) reagent was promoted by the 
increase in reaction temperature, taking to account the presence of N,N-dimethylformamide in the 
reaction mixtures. This polar molecule is highly sensitive to MW irradiation and allows higher 
temperatures [28,29]. In fact, under our MW-assisted chloroformylation conditions, the presence of 
DMF masked the specific effect of MWs, and the accelerations are attributed mainly to the 
superheating effect of the solvent. However, in order to determine whether there is a specific MW 
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effect accelerating the reaction with respect to conventional heating, we carried out all the experiments 
using classical heating (thermostated oil bath) in the same conditions as under MWAS (time, profiles 
of rise in temperature, vessels, etc.). When the starting materials were heated at 50 °C for 5 min to 2 h 
without solvent, only a complex mixture of by-products was detected (TLC and 1H-NMR). 
The improvement achieved with MWAS (Method A) could be associated with the reaction 
mechanism and the evolution of polarity during the MW-assisted reaction. This reaction was shown to 
proceed through a mechanism involving several steps, beginning with the formation of the 
electrophilic VH reagent from DMF and POCl3. Reaction of the electrophilic reagent with the enolic 
form of the intermediate compound I proceeded through a pyridone intermediate, followed by reaction 
with POCl3 to give the chloro derivative intermediate, which, via subsequent hydrolysis, provided the 
desired 6-chloro-5-formyl-1,4-DHP II (Scheme 2). 
Scheme 2. The proposed mechanism of the chloroformylation reaction. 
 
On the basis of the previous result and the postulated mechanism, we propose that the specific MW 
effect is attributable to the following: Improvements in the formation of the chloroiminium species  
(VH reagent), and the enhancement of the subsequent reaction of the electrophilic reagent with the 
enolic form of the intermediate compound I. In both cases, the polarity increased from the ground state 
to the transition state (Scheme 3), thereby resulting in an enhancement of reactivity as a result of a 
decrease in the corresponding activation energy [30]. 
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Scheme 3. Postulated transition states (ET) for the formation of VH reagent and for the 
reaction between the electrophilic reagent and the enolic form in the chloroformylation reaction. 
 
The final products IIa–j were characterized by melting point, NMR and mass spectral data. Most 
compounds synthetized in this study were known and their spectral characterization showed 
satisfactory agreement with previous literature data [12,23-25]. The 1H-NMR spectra of the DHP 
derivatives IIa–j showed two singlets at δ ~ 10.6 ppm and δ ~ 9.6 ppm, corresponding to the NH and 
CHO protons, respectively. The singlet corresponding to the H4 proton appeared in the range of δ  
4.9–5.3 ppm and the methyl group on C-2 as a singlet at δ ~ 2.3 ppm. The alkoxycarbonyl group on C3 
appeared as a singlet (δ ~ 3.5 ppm) in the case of R = CH3 (compounds 5a–f) and as a quadruplet-
triplet when R = CH2CH3 (compounds 5g–j) at δ ~ 3.9 ppm and δ ~ 1.1 ppm, respectively. The  
1H-NMR spectra also showed signals corresponding to the phenyl protons, depending upon the 
substitution present on the aromatic ring. The 13C-NMR spectra of these compounds displayed signals 
in the carbonyl, aromatic and aliphatic regions. For the nitrogen heterocyclic ring, the spectra showed 
four quaternary carbon signals (C-2, C-3, C-5, and C-6), and one secondary carbon signal (C-4). The 
formyl group (CHO) carbon in these systems appeared at 187–186 ppm. The alkoxycarbonyl group 
appeared at 166.2–166.9 ppm. 
MWAS of chloroformyl derivatives IIa–j offers considerable improvements over our previously 
reported conventional Vilsmeier-Haack chloroformylation [12,23-25]. The reaction time was notably 
reduced (conventional synthesis: 18 h, and MWAS: 5 min), and the final product was obtained with 
excellent purity and hence could be used in further synthetic steps without any need for wasteful 
purification. 
2.2. Microwave Assisted Synthesis (MWAS) of 4-Arylsubstituted-4,7-dihydrofuro[3,4-b]pyridine-
2,5(1H,3H)-diones IIIa–i 
Some substituents on the 1,4-DHP ring have a dramatic effect on its biological activities [31]. 
Specifically, cyclohexanone and -lactone rings fused to the 1,4-DHP moiety result in a striking effect 
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on the entry of calcium ions into the intracellular space (calcium antagonist effect) [32]. Our classical 
method for the synthesis of 4-arylsubstituted-4,7-dihydrofuro[3,4-b]pyridine-2,5(1H,3H)-diones III in 
moderate to good yields, comprised a one-pot reaction of the alkyl 2-methyl 6-oxo-1,4,5,6-
tetrahydropyridine-3-carboxylates I with N-bromosuccinimide (NBS) as the brominating reagent by 
refluxing in chloroform in 12–14 h [33-35]. The microwave-accelerated lactonization to obtain the 
furo[3,4-b]pyridines IIIa–i were performed in a one-step procedure by reaction of previously 
synthesized I with NBS without solvent. This reaction was carried out at 240 Watts and under a 
controlled temperature of 80 °C for 10 min (Scheme 4). When the irradiation was stopped, the mixture 
was treated with the adequate solvents and filtered to give the pure products IIIa–i in excellent yields. 
Scheme 4. Schematic representation for the synthesis of compounds IIIa–i. 
 
Table 2 shows the results obtained for the MWAS of compounds IIIa–i, compared with the 
classical method previously reported by our group (Method B) [33-35]. To check the possibility of 
intervention of specific non-pure thermal effects of MWs, the reaction was performed by heating in 
thermostated oil bath under the same experimental conditions used for MW irradiation (time, profiles 
of rise in temperature, vessels). In no case was a reaction detected by TLC at 10 min of reaction, and 
after 2 h of reaction the TLC showed a complex mixture of byproducts. 
Table 2. Results of MWASwithout solvent (Method A) of 4-arylsubstituted-4,7-dihydro-
furo[3,4-b]pyridine-2,5(1H,3H)-diones IIIa–j and comparison with the conventional 
method (Method B) [33-35]. 
Product R Ar Method T(°C)  t (min) Yield (%) 
IIIa -CH3 
-CH2CH3 




















































Molecules 2011, 16 9627 
 
 



















































































































In all cases, the MWAS yields for these compounds (Method A) were higher than those achieved 
previously with conventional synthesis conditions [33-35]. Moreover, the time of reaction was 
dramatically reduced from 12 h (720 min) in the conventional synthesis (Method B) to 10 min for the 
MWAS method. The presence of two distinct alkoxy groups in the three positions of the starting 
dihydropyridine derivative I did not significantly alter the yields obtained. 
Lactonization could be accounted for by the Wohl-Ziegler bromination (allylic bromination) [36] at 
the methyl group to the 2nd position of the heterocycle I, yielding the non-isolable monobrominated 
intermediate via a free radical process, followed by intramolecular cyclization to give the 
corresponding -lactone (Scheme 5) in similar way to the pyridinium bromide perbromide procedure 
reported for 1,4-DHPs [37]. Given the higher reactivity of the radical species, we propose that the 
second stage is the determining step in the mechanism postulated for this reaction. The intramolecular 
cyclization could take place through a polar mechanism. The non-isolable monobrominated 
intermediate leads to a charged species as a result of an intramolecular nucleophilic attack through 
SN2 mechanism. Subsequently, the bromide originated in this process could act as a nucleophile on the 
methyl carbon, with the loss of a bromomethane molecule, to obtain the final product of reaction III 
(Scheme 5). In both postulated steps for this second stage, the polarity is increased from the ground 
states to the transition states (ET-1 and ET-2) (Scheme 5), thus resulting in an enhancement of 
reactivity under MW irradiation by lowering the activation energy [30]. 
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Scheme 5. The mechanism and the transition states postulated for the second step of the 
lactonization reaction. 
 
It is possible that the increase in the rate of the second stage of the lactonization reaction under MW 
irradiation prevents the accumulation of the monobrominated intermediate, thus reducing the risk of 
polybromation and consequently increasing yields. 
The final products IIIa–i were characterized by melting point, NMR and mass spectral data. Most 
compounds synthesized in this study were known and their spectral characterization showed 
satisfactory agreement with the previous literature data [33-35]. The 1H-NMR spectra of DHP 
derivatives IIIa–i showed one singlet corresponding to the NH at δ ~ 10.7–11.3 ppm. The signals 
corresponding to the lactone ring methylene protons appeared as an AB system at δ 4.97 and δ 5.37 
ppm, due to the germinal coupling between them, and confirmed the formation of lactone-fused DHP. 
The 13C-NMR spectra of these compounds displayed signals in the carbonyl, aromatic, and aliphatic 
regions. For the nitrogen heterocyclic ring, the spectra showed three quaternary carbon signals (C-2, 
C-4a, and C-7a), one secondary carbon signal (C-4), and one primary carbon signal (C-3). The signals 
of the quaternary carbons C-7a appeared at higher δ values than those expected for typical olefinic 
carbon atoms. In contrast, the quaternary carbon C-4a was observed at unusually lower δ values. This 
displacement of the signals is due to the strong push–pull effect of the groups linked to the olefinic 
double bonds [33-35]. 
The MWAS without solvent of furopyridone derivatives IIIa–i (Method A) thus offers considerable 
advantages over our previous reported conventional lactonization synthesis [33-35]. The reaction time 
was notably reduced [conventional synthesis (Method B): 12 h, and MWAS (Method A): 10 min), and 
the final product was obtained in excellent purity and yield and hence could be used in further 
procedures without the need for any wasteful purification steps. 
3. Experimental 
3.1. General 
Reagents and solvents were purchased from Fluka or Aldrich. The progress of the reaction and the 
purity of compounds were monitored on TLC analytical silica gel plates (Merck 60F250) using  
n-hexane-chloroform-ethyl acetate (3:2:1) and benzene-methanol (7:2) as eluents for the compounds 
IIa–j and IIIa–I, respectively. The MW irradiation was provided by a CEM Discover LabMate 
Focused Single Mode MW Synthesis Reactor, which produced continuous stirring and irradiation with 
control of pressure and temperature. Melting points were determined in capillary tubes in an 
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Electrothermal C14500 apparatus and are uncorrected. The NMR spectra were recorded on a Mercury 
400 spectrometer [400 MHz (1H) and 75.4 MHz (13C)]. Chemical shifts are given as δ values against 
tetramethylsilane as the internal standard and J values are given in Hz. Mass spectra were obtained in a 
LC/MSD-TOF(2006) Instrument (Agilent Technologies). 
3.2. General Procedure for the MWAS of 4-Arylsubstituted alkyl 1,4,5,6-Tetrahydro-2-methyl-6-
oxopyridine-3-carboxylates I 
4-Arylsubstituted alkyl 1,4,5,6-tetrahydro-2-methyl-6-oxopyridine-3-carboxylates I were prepared 
following the previously reported procedure [20]. In this case the MW irradiation was provided by a 
CEM Discover LabMate Focused Single Mode MW Synthesis Reactor, and the reaction mixtures were 
irradiated for 10 min at 250 Watts. All the compounds were characterized by determination of physical 
constants and by NMR spectroscopy, which coincided with those previously reported for these 
compounds [20]. 
3.3. General Procedure for the MWAS of Methyl 4-Arylsubstituted-6-chloro-5-formyl-2-methyl-1,4-
dihydropyridine-3-carboxylates IIa–j 
4-Aryl-substituted alkyl 1,4,5,6-tetrahydro-2-methyl-6-oxopyridine-3-carboxylates (I, 7 mmol) 
were added to the Vilsmeier-Haack reagent prepared from a mixture of POCl3 (1.1 mL, 12.2 mmol) 
and DMF (1.4 mL, 18.2 mmol) at 5 °C. This mixture was then irradiated in the CEM Discover reactor 
at 180 Watts for 5 min at the controlled temperature of 50 °C. After the completion of the reaction, an 
aqueous sodium acetate solution was added (12 g in 21 mL of water). After 0.5 h, the mixture was 
partitioned between water and chloroform, and the aqueous phase was extracted with ethyl acetate. 
The organic phases were mixed and dried with anhydrous magnesium sulfate. The organic solvent was 
removed in vacuo and the solid was precipitated from diethyl ether, filtered and washed with small 
portions of cooled ethanol. The chracterization data of the compounds is given below. 
Methyl 6-chloro-5-formy1-2-methyl-4-(2′-nitrophenyl)-1,4-dihydropyridine-3-carboxylate (IIa). 
Yellow solid; m.p. 178–180 °C; yield: 69%; 1H-NMR (DMSO-d6)  2.34 (s, 3H, CH3), 3.55 (s, 3H, 
OCH3), 4.95 (s, 1H, H4), 7.64–7.53 (m, 3H, Ar), 8.04 (dt, J = 7.7 Hz, J = 2.1 Hz, 1H, Ar), 9.65 (s, 1H, 
CHO), 10.56 (s, 1H, NH); 13C-NMR (DMSO-d6)  18.6 (CH3), 39.0 (C4), 60.6 (OCH3), 111.3 (C3), 
104.8 (C5), 122.3 (C5′), 130.1 (C3′), 134.0 (C4′), 135.0 (C6′), 144.1 (C2), 147.1 (C6), 147.3 (C2′), 
148.6 (C1′), 166.4 (COOCH3), 187.3 (CHO); ESI-MS: m/z 337 [M+H]
+. 
Methyl 6-chloro-5-formy1-2-methyl-4-(3′-nitrophenyl)-1,4-dihydropyridine-3-carboxylate (IIb). 
Yellow solid; m.p. 213–214 °C; yield: 68%; 1H-NMR (DMSO-d6)  2.36 (s, 3H, CH3), 3.54 (s, 3H, 
OCH3), 5.05 (s, 1H, H4), 7.62–7.58 (m, 2H, Ar), 8.00 (t, J = 2.0 Hz, 1H, Ar), 8.05 (dt, J = 7.5 Hz,  
J = 2.0 Hz, 1H, Ar), 9.67 (s, 1H, CHO), 10.53 (s, 1H, NH); 13C-NMR (DMSO-d6)  17.9 (CH3), 37.9 
(C4), 51.2 (OCH3), 103.6 (C5), 110.4 (C3), 120.8 (C2′), 121.0 (C4), 129.6 (C6′), 133.6 (C5), 143.5 
(C2), 147.6 (C3′), 147.7 (C6), 149.3 (C1′), 166.2 (COOCH3), 186.5 (CHO); ESI-MS: m/z 337 [M+H]
+. 
Methyl 6-chloro-5-formyl-2-methyl-4-(4′-nitrophenyl)-1,4-dihydropyridine-3-carboxylate (IIc). 
Yellow solid; m.p. 190–192 °C; yield: 65%; 1H-NMR (DMSO-d6)  2.34 (s, 3H, CH3), 3,54 (s, 3H, 
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OCH3), 5.03 (s, 1H, H4), 7.44 (d, J = 7.9 Hz, 2H, Ar), 8,12 (d, J = 7.9 Hz, 2H, Ar), 9,67 (s, 1H, CHO), 
10.48 (s, 1H, NH); 13C-NMR (DMSO-d6)  ppm 18.7 (CH3), 39.2 (C4), 51.2 (OCH3), 104.6 (C5), 
111.1 (C3), 124.4 (C3′,C5′), 129.6 (C2′,C6′), 141.1 (C2), 147.1 (C4′), 146.9 (C6), 153.7 (C1′), 166.6 
(COOCH3), 187.4 (CHO); ESI-MS: m/z 337 [M+H]
+. 
Methyl 6-chloro-5-formyl-4-(4-methoxycarbonylphenyl)-2-methyl-l,4dihydropyridine-3-carboxylate 
(IId). White solid; mp 202–204 °C; yield: 63%; 1H-NMR (DMSO-d6)  2.34 (s, 3H, CH3), 3.53 (s, 3H, 
OCH3), 3.79 (s, 3H, OCH3), 5.00 (s, 1H, CH), 7.29 (d, J = 7.9 Hz, 2H, Ar), 7.84 (d, J = 7.9 Hz, 2H, 
Ar), 9.67 (s, 1H, HCO), 10.46 (s, 1H, NH); 13C-NMR (DMSO-d6)  17.8 (CH3), 38.0 (C4), 51.1 
(OCH3), 103.8 (C3), 110.5 (C5), 127.6 (C3′,C5′), 129.3 (C2′,C6′), 143.1 (C2),146.1 (C6), 150.7 (C1′), 
166.4 (COOCH3), 186.5 (CHO); ESI-MS: m/z 350 [M+H]
+. 
Methyl 4-(2′,3′-dihidroxyphenyl)-6-chloro-5-formyl-2-methyl-l,4dihydropyridine-3-carboxylate (IIe). 
White solid; mp 239–241 °C; yield: 70%; 1H-NMR (DMSO-d6)  2.24 (s, 3H, CH3), 3,77 (s, 3H, 
OCH3), 4.98 (s, 1H, H4), 5.40 (brs, 2H, OH), 6.62(m, 3H, Ar) 9.71 (s, 1H, HCO), 10.38 (s, 1H, NH); 
13C-NMR (DMSO-d6)  17.8 (CH3), 38.2 (C4), 51.3 (OCH3), 103.7 (C3), 110.3 (C5), 114.3 (C4′), 
122.2 (C5′), 123.2 (C6′), 124.1 (C1′), 145.2 (C3′), 147 (C2′), 143.1 (C2), 146.5 (C6), 150.3 (C1′), 
166.6 (COOCH3), 186.8 (CHO); ESI-MS: m/z 324 [M+H]
+. 
Methyl 6-chloro-4-(4′-dimethylaminophenyl)-5-formyl-2-methyl-1,4-dihydropyridine-3-carboxylate 
(IIf). Yellow solid; m.p. 290–292 °C; yield: 60%; 1H-NMR (DMSO-d6)  2.34 (s, 3H, CH3), 3.10 (s, 
6H, CH3), 3,52 (s, 3H, OCH3), 5.00 (s, 1H, H4), 7.39 (d, J = 7.9 Hz, 2H, Ar), 8,08 (d, J = 7.9 Hz, 2H, 
Ar), 9,77 (s, 1H, CHO), 10.48 (s, 1H, NH); 13C-NMR (DMSO-d6)  18.7 (CH3), 39.2 (C4), 41.7 
(2CH3), 51.2 (OCH3), 104.4 (C5), 110.9 (C3), 124.2 (C3′,C5′), 129.8 (C2′,C6′), 141.1 (C2), 147.2 
(C4′), 146.7 (C6), 153.5 (C1′), 166.8 (COOCH3), 187.2 (CHO). ESI-MS: m/z 335 [M+H]
+. 
Ethyl 6-chloro-5-formyl-2-methyl-4-phenyl-1,4-dihydropyridine-3-carboxylate (IIg). White solid; m.p. 
201–202 °C; yield: 62%; 1H-NMR (DMSO-d6)  1.10 (t, J = 7.1 Hz, 3H, CH3), 2.33 (s, 3H, CH3), 4.02 
(q, J = 7.1 Hz, 2H, OCH2), 4.93 (s, 1H, H4), 7.09 (d, J = 7.8 Hz, 2H, Ar), 7.31–7.11 (m, 3H, Ar), 9.72 
(s, 1H, CHO), 10.35 (s, 1H, NH); 13C-NMR (DMSO-d6)  14.6 (CH3), 18.3 (CH3), 38.1 (C4), 59.8 
(OCH2), 103.9 (C5), 109.3 (C3), 126.1 (C4′), 126.6 (C2′,C6′), 128.2 (C3′,C5′), 144.3 (C2), 146.9 (C1′), 
147.9 (C6), 166.2 (COOCH2CH3), 187.4 (CHO); ESI-MS: m/z 306 [M+H]
+.  
Ethyl 6-chloro-5-formyl-2-methyl-4-(2′-nitrophenyl)-1,4-dihydropyridine-3-carboxylate (IIh). Yelow 
solid; m.p. 198–200 °C; yield: 65%; 1H-NMR (DMSO-d6)  1.10 (t, J =7.1 Hz, 3H, CH3), 2.35 (s, 3H, 
CH3), 3.99 (q, J =7.1 Hz, 2H, OCH2), 5.03 (s, 1H, H4), 7.64–7.53 (s, 2H, Ar), 7.96 (t, J = 2.0 Hz, 1H, 
Ar), 8.02 (dt, J = 7.7 Hz, J = 2.0 Hz, 1H, Ar), 9.68 (s, 1H, CHO), 10.52 (1H, s, NH); 13C-NMR  
(DMSO-d6)  14.8 (CH3), 18.6 (CH3), 39.0 (C4), 60.6 (OCH2), 104.8 (C5), 111.3 (C3), 122.4 (C3′), 
122.7 (C5′), 130.7 (C4′), 135.0 (C6′), 144.1 (C2), 147.1 (C6), 148.4 (C2′), 148,6 (C1′), 166.5 
(COOCH2CH3), 187.4 (CHO); ESI-MS: m/z 351 [M+H]+. 
Ethyl 4-(2′,3′-dihidroxyphenyl)-6-chloro-5-formyl-2-methyl-l,4dihydropyridine-3-carboxylate (IIi). 
White solid; mp 248–250 °C; yield: 63%; 1H-NMR (DMSO-d6)  1.28 (t, 3H, CH3), 4,17 (q, 2H, 
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OCH2), 4.98 (s, 1H, H4), 5.40 (brs, 2H, OH), 6.62(m, 3H, Ar) 9.71 (s, 1H, HCO), 10.38 (s, 1H, NH); 
13C-NMR (DMSO-d6)  14.8 (CH3), 18.5 (CH3), 38.2 (C4), 61.3 (OCH2), 103.7 (C3), 110.3 (C5), 
114.3 (C4′), 122.2 (C5′), 123.2 (C6′), 124.1 (C1′), 145.2 (C3′), 147 (C2′), 143.1 (C2),146.5 (C6), 150.3 
(C1′), 166.6 (COOCH3), 186.8 (CHO); ESI-MS: m/z 338 [M+H]
+. 
Ethyl 6-chloro-4-(4′-dimethylaminophenyl)-5-formyl-2-methyl-1,4-dihydropyridine-3-carboxylate 
(IIj). Yellow solid; m.p. 300–302 °C; yield: 64%; 1H-NMR (DMSO-d6)  1.25 (t, 3H, CH3), 3.10 (s, 
6H, CH3), 4,17 (q, 2H, OCH2), 4.89 (s, 1H, H4), 7.35 (d, J = 7.9 Hz, 2H, Ar), 8,02 (d, J = 7.9 Hz, 2H, 
Ar), 9,87 (s, 1H, CHO), 10.48 (s, 1H, NH); 13C-NMR (DMSO-d6)  14.5 (CH3), 18.3 (CH3), 39.2 (C4), 
41.7 (2CH3), 61.5 (OCH2), 104.4 (C5), 110.9 (C3), 124.2 (C3′,C5′), 129.8 (C2′,C6′), 141.1 (C2), 147.2 
(C4′), 146.7 (C6), 153.5 (C1′), 166.8 (COOCH3), 187.2 (CHO). ESI-MS: m/z 349 [M+H]
+. 
3.4. General Procedure for the MWAS of 4-Arylsubstituted-4,7-dihydrofuro[3,4-b]pyridine-
2,5(1H,3H)-diones IIIa–i 
A mixture of 4-aryl-substituted alkyl 1,4,5,6-tetrahydro-2-methyl-6-oxopyridine-3-carboxylate (I,  
5 mmol) and N-bromosuccinimide (0.89 g, 5 mmol) was irradiated without solvent in the CEM 
Discover reactor at 240 Watts for 10 min, and at the controlled temperature of 80 °C. When the 
irradiation was stopped, the mixture was treated with chloroform, and the solid obtained was filtered 
and washed with small portion of cool chloroform and diethyl ether to give the pure products. 
Compound data is given below. 
4-(3′-Nitrophenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIa). Pale yellow solid; m.p. 
218–219 °C; yield: 80% from I (R = Me), and 85% from I (R = Et); 1H-NMR (DMSO-d6)  3.03 (dd, 
1H, H3b, J = 16.7 Hz, J = 3.8 Hz B part of ABX), 3.64 (dd, 1H, H3a, J = 16.7 Hz, J = 8.9 Hz A part of 
ABX), 4.85 (dd, 1H, H4, J = 8.9 Hz, J = 3.8 Hz, X part of ABX), 5.34 (dd, 2H, OCH2),  
8.38–7.82 (m, 4H, Ar), 11.27 (s, 1H, NH); 13C-NMR (DMSO-d6)  29.6 (C4), 38.1 (C3), 65.5 (C7), 
99.8 (C4a), 124.7 (C5′), 128.7 (C4′), 129.1 (C6′), 133.8 (C3′), 135.1 (C1′), 148.6 (C2′), 162.0 (C7a), 
168.0 (C5), 170.4 (C2); ESI-MS: m/z 275 [M+H]+. 
4-(3′-Nitrophenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIb). Pale yellow solid; m.p. 
234–235 °C; yield: 79% from I (R = Me), and 82% from I (R = Et); 1H-NMR (DMSO-d6)  2.67 (d, 
1H, H3b, J = 16.9 Hz, J = 8.9 Hz B part of ABX) 3.15 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part of 
ABX), 4 .25 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz X part of ABX); 4.97 (dd, 2H, OCH2), 8.12–7.64 (m, 
4H, Ar), 10.86 (s, 1H, NH); 13C-NMR (75 MHz, DMSO-d6)  33.1 (C4), 38.0 (C3), 65.5 (C7), 100.5 
(C4a), 148.0; 143.9; 133.6; 130.3; 122.1; 121.6 (C aromatics), 161.4 (C7a), 169.3 (C5), 170.8 (C2); 
ESI-MS: m/z 275 [M+H]+. 
4-(4′-Nitrophenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIc). Pale yellow solid; m.p. 
241–243 °C; yield: 82% from I (R = Me), and 85% from I (R = Et); 1H-NMR (DMSO-d6)  2.67 (dd, 
1H, H3b, J = 16.6 Hz, J = 3.6 Hz B part of ABX), 3.15 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part of 
ABX), 4.25 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz, X part of ABX), 4.97 (dd, 2H, OCH2), 8.15–7.42 (m; 
4H; Ar), 10.81 (s, 1H, NH); 13C-NMR (DMSO-d6)  33.1 (C4), 38.0 (C3), 65.5 (C7), 100.5 (C4a), 
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148.0, 143.9, 133.6, 130.3, 122.1,121.6 (C aromatics), 161.4 (C7a), 169.3 (C5), 170.8 (C2); ESI-MS: 
m/z 275 [M+H]+. 
4-(4′-Tolyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIId). White solid; m.p. 200–202 °C; 
yield: 89% from I (R = Me), and 85% from I (R = Et); 1H-NMR (DMSO-d6)  2.65 (dd, 1H, H3b,  
J = 16.6 Hz, J = 3.6 Hz B part of ABX), 3.15 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part of ABX), 
4.26 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz, X part of ABX), 4.95 (dd, 2H, OCH2), 7.32–8.12 (m; 4H; 
Ar), 10.78 (s, 1H, NH); 13C-NMR (DMSO-d6)  33.3 (C4), 38.2 (C3), 65.3 (C7), 100.4 (C4a), 121.5, 
122.5, 130.1, 133.6, 144.0, 148.1 (C aromatics), 161.4 (C7a), 169.3 (C5), 170.8 (C2); ESI-MS: m/z 
244 [M+H]+. 
4-(2′,3′-Dihydroxyphenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIe). White solid; m.p. 
291–293 °C; yield: 72% from I (R = Me), and 79% from I (R = Et); 1H-NMR (DMSO-d6)  2.65 (d, 
1H, H3b, J = 16.9 Hz, J = 8.9 Hz B part of ABX) 3.10 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part of 
ABX), 4.18 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz X part of ABX); 4.92 (dd, 2H, OCH2), 7.54–8.08 (m, 
3H, Ar), 10.88 (s, 1H, NH); 13C-NMR (DMSO-d6)  30.9 (C4), 38.5 (C3), 65.3 (C7), 99.8 (C4a), 
145.2; 145.9; 130.6; 123.7; 122.8; 119.9 (C aromatics), 162.1 (C7a), 169.3 (C5), 170.5 (C2); ESI-MS: 
m/z 262 [M+H]+. 
4-(4′-(Dimethylamino)phenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIf). Yellow solid; 
m.p. 243–245 °C; yield: 84% from I (R = Me), and 85% from I (R = Et); 1H-NMR (DMSO-d6)  2.63 
(d, 1H, H3b, J = 16.9 Hz, J = 8.9 Hz B part of ABX), 2.99 (s, 6H, 2CH3), 3.05 (dd, 1H, H3a,  
J = 16.6 Hz, J = 8.9 Hz A part of ABX), 4.09 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz X part of ABX); 
4.85 (dd, 2H, OCH2), 7.14–7.78 (m, 4H, Ar), 10.88 (s, 1H, NH); 
13C-NMR (DMSO-d6)  32.8 (C4), 
38.5 (C3), 40.9 (NCH3), 65.2 (C7), 99.9 (C4a), 119.9, 120.2; 128.9; 129.6, 132.7; 148.2, (C aromatics), 
162.0 (C7a), 169.0 (C5), 170.1 (C2); ESI-MS: m/z 273 [M+H]+. 
4-Phenyl-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIg). White solid; m.p. 239–240 °C; 
yield: 84% from I (R = Me), and 85% from I (R = Et); 1H-NMR (DMSO-d6)  2.57 (d, 1H, H3b,  
J = 16.6 Hz, J = 3.6 Hz B part of ABX), 3.12 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part of ABX), 
4.01 (d, 1H, H4, J = 9.0 Hz, J = 3.6 Hz, X part of ABX), 4.91 (dd, 2H, OCH2), 7.18–7.35 (m; 4H; Ar), 
10.74 (s, 1H, NH); 13C-NMR (DMSO-d6)  33.3 (C4), 38.4 (C3), 65.3 (C7), 101.7 (C4a), 126.5, 126.9, 
128.7, 144.8 (C aromatics), 160.7 (C7a), 169.0 (C5), 170.9 (C2); ESI-MS: m/z 230 [M+H]+. 
4-(3′-Methoxyphenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIh). Pale yellow solid; 
m.p. 268–270 °C; yield: 88% from I (R = Me), and 85% from I (R = Et); 1H-NMR (DMSO-d6)  2.61 
(d, 1H, H3b, J=16.9 Hz, J= 8.9 Hz B part of ABX) 3.14 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part 
of ABX), 3.75 (s, 3H, OCH3), 4.20 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz X part of ABX); 4.82 (dd, 2H, 
OCH2), 7.43–8.12 (m, 4H, Ar), 10.70 (s, 1H, NH); 
13C-NMR (DMSO-d6)  33.5 (C4), 38.3 (C3), 53.2 
(OCH3), 65.3 (C7), 101.0 (C4a), 120.9, 121.9, 130.3, 133.4, 141.9, 158.2 (C aromatics), 161.8 (C7a), 
169.0 (C5), 170.1 (C2), ESI-MS: m/z 260 [M+H]+. 
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4-(3′,4′,5′-Trimethoxyphenyl)-3,4-dihydrofuro[3,4-b]pyridine-2,5-(1H,7H)-dione (IIIi). Yellow solid; 
m.p. 288–290 °C; yield: 83% from I (R = Me), and 81% from I (R = Et); 1H-NMR (DMSO-d6)  2.63 
(d, 1H, H3b, J = 16.9 Hz, J = 8.9 Hz B part of ABX) 3.10 (dd, 1H, H3a, J = 16.6 Hz, J = 8.9 Hz A part 
of ABX), 3.83 (s, 9H, 3OCH3), 4.18 (dd, 1H, H4, J = 9.0 Hz, J = 3.6 Hz X part of ABX); 4.82 (dd, 2H, 
OCH2), 7.53 (s, 2H, Ar), 10.70 (s, 1H, NH); 
13C-NMR (DMSO-d6)  33.5 (C4), 38.3 (C3), 56.2 
(2OCH3), 60.8 (OCH3), 65.3 (C7), 101.0 (C4a), 109.9, 134.9, 136.5, 153.4 (C aromatics), 161.9 (C7a), 
169.2 (C5), 170.3 (C2), ESI-MS: m/z 320 [M+H]+. 
4. Conclusions 
The MW-assisted methods presented here for the synthesis of alkyl 4-arylsubstituted-6-chloro-5-
formyl-2-methyl-1,4-dihydropyridine-3-carboxylates IIa–j and 4-arylsubstituted-4,7-dihydrofuro[3,4-
b]pyridine-2,5-(1H,3H)-diones IIIa–i are straightforward, mild, and efficient. In both cases, the overall 
process was more energy-efficient than classical heating, since direct “in-core” heating of the medium 
occurred. These protocols have advantages over other techniques as they offer a shorter reaction times, 
cleaner reaction profiles, solvent-free reactions (for compounds IIIa–i), higher yields and an easy  
eco-friendly work-up. 
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